Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹71.80
Market cap
₹18.09 Cr
Revenue (annual)
₹6.14 Cr
Net profit (annual)
₹0.51 Cr
P/E (TTM)
6.5×Sector 47.4×
Promoter holding
50.60%-15.40% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:39 IST BSE
Annual General Meeting

Colinz Laboratories Annual General Meeting

Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.

14:48 IST BSE
Annual General Meeting

Colinz Laboratories Annual General Meeting

Colinz Laboratories Ltd has issued the notice for its 40th Annual General Meeting scheduled for September 22, 2026. The agenda includes director re-appointments and auditor report adoption.